Of the remaining two cell lines (HCC1937, HCC202), both are from Caucasian women, from primary ductal carcinoma, are ER and PR negative, p53 mutation negative, and positive for EFP2 and CK19 expression; however, they differed in BRCA1 mutation and HER2 status. This evidence concerns the gene PGR and breast ductal adenocarcinoma.